Iran voices alarm over a new peace treaty between Azerbaijan and Armenia, brokered by the US. The deal could reshape regional power dynamics and threaten Iran's influence.
The EU has recommended lenacapavir, an injectable drug for HIV prevention, which could drastically reduce transmission rates. With nearly 100% effectiveness, it promises a new era in combating HIV.
The European Medicines Agency has recommended the approval of lenacapavir, a twice-yearly injectable drug that could revolutionize HIV prevention and significantly reduce transmission rates globally.
The WHO's endorsement of lenacapavir, a twice-yearly injectable drug, could transform HIV prevention for high-risk groups, especially amid funding concerns. This breakthrough may help millions and push us closer to an AIDS-free world.
In a race against time, Senate Republicans are modifying Trump's $9.4 billion spending cuts package. Key changes include preserving funding for PEPFAR amidst bipartisan concerns. Will they secure enough votes?
The UNAIDS annual report warns that decades of progress in combating HIV/AIDS are jeopardized by significant funding cuts, particularly from U.S. donors, threatening millions of lives in the coming years.
Recent U.S. funding cuts to AIDS programs have sparked alarms, with UNAIDS warning of potential catastrophic rises in HIV infections and AIDS-related deaths. The future of global health hangs in the balance.
The recent cuts to US aid threaten the future of HIV/AIDS treatment in South Africa. Thousands of patients face uncertainty as clinics close, jeopardizing years of progress in combating the disease.
A new Covid variant, NB.1.8.1, raises alarms for its potential to spread rapidly and evade antibodies. Meanwhile, the FDA approves a long-lasting HIV injection, and concerns about public safety arise with ICE's rule changes.
In a crucial turn of events, the Trump administration has lifted its freeze on nearly $20 million for HIV prevention programs following significant public outcry. This funding is vital for combating new infections and supporting the LGBTQ+ community.